- Home
- MDXG vs PCRX Comparison
MDXG vs PCRX Comparison
Compare MDXG & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- PCRX
- Stock Information
- Founded
- MDXG 2006
- PCRX 2006
- Country
- MDXG United States
- PCRX United States
- Employees
- MDXG N/A
- PCRX N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- MDXG Health Care
- PCRX Health Care
- Exchange
- MDXG Nasdaq
- PCRX Nasdaq
- Market Cap
- MDXG 1.2B
- PCRX 1.1B
- IPO Year
- MDXG N/A
- PCRX 2011
- Fundamental
- Price
- MDXG $6.68
- PCRX $24.65
- Analyst Decision
- MDXG Strong Buy
- PCRX Buy
- Analyst Count
- MDXG 3
- PCRX 9
- Target Price
- MDXG $12.00
- PCRX $30.11
- AVG Volume (30 Days)
- MDXG 587.5K
- PCRX 1.2M
- Earning Date
- MDXG 04-30-2025
- PCRX 05-06-2025
- Dividend Yield
- MDXG N/A
- PCRX N/A
- EPS Growth
- MDXG N/A
- PCRX N/A
- EPS
- MDXG 0.28
- PCRX N/A
- Revenue
- MDXG $348,879,000.00
- PCRX $700,966,000.00
- Revenue This Year
- MDXG $10.04
- PCRX $9.48
- Revenue Next Year
- MDXG $11.53
- PCRX $11.31
- P/E Ratio
- MDXG $23.86
- PCRX N/A
- Revenue Growth
- MDXG 8.52
- PCRX 3.85
- 52 Week Low
- MDXG $5.47
- PCRX $11.16
- 52 Week High
- MDXG $10.14
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- MDXG 32.24
- PCRX 51.22
- Support Level
- MDXG $6.55
- PCRX $24.10
- Resistance Level
- MDXG $7.34
- PCRX $25.35
- Average True Range (ATR)
- MDXG 0.36
- PCRX 1.49
- MACD
- MDXG -0.04
- PCRX 0.01
- Stochastic Oscillator
- MDXG 15.75
- PCRX 48.89
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.